Topic

Webcasts

Webinar Date/Time: Tuesday, September 19th, 2023 at 8am PDT | 11am EDT | 4pm BST

Trends in Commercial Forecasting: Insights from IQVIA’s Annual Survey

Meg Rivers is the former managing editor of 

Articles

In this exclusive Q&A, Vishali Amin, chief of staff to the office of the president and senior director of customer success for Kalderos, discusses the biggest hurdles to drug affordability, how patients can become aware of drug discounts, how drugs are selected for regulatory discount programs, and drug pricing strategies.

Current Drug Affordability Challenges

In this exclusive Q&A, Alice Valder Curran, life sciences regulatory expert and partner, Hogan Lovells LLP, shares her perspective on the biggest drug pricing challenges today, current efforts to lower drug pricing, and the Inflation Reduction Act. 

Drug Pricing from a Legal Perspective & IRA Predictions

Frederique Welgryn, global vice president for women's health, Perrigo, shares insight into the approval of Opill (norgestrel), a progestin-only contraception, in this exclusive Q&A.

FDA Approves First Nonprescription Birth Control 

Corey Ford is the vice president of reimbursement and policy insights for AmerisourceBergen.

As we approach the one-year anniversary of the IRA being signed into law, questions remain about how the new law will reverberate changes across the biopharma industry. 

AdobeStock_527614812_Inflation Reduction Act is shown using the text and the US flag, By Andrii

What’s Next for Biopharma Under the Inflation Reduction Act

Webinar Date/Time: Tue, Aug 29, 2023 10:00 AM EDT

Addressing Diversity in Patient Recruitment for Clinical Research

Videos

Elizabeth (Beth) Garner, chief scientific officer for Ferring Pharmaceuticals, discusses what it was like transitioning from working as a gynecologic oncologist and seeing patients to working in pharma, specifically clinical trials. 

From Physician to Pharma: Gynecologic Oncologist Enters Clinical Trials Space

Artificial intelligence is steadily becoming a game changer for the pharma industry, particularly in commercialization activities, such as sales and marketing—and efforts to help highly sought treatments reach the right patients.

Harnessing AI  for Pharma Sales

Rose Blackburne, MD, MBA, vice president, global head, general medicine, PPD Clinical Research, Thermo Fisher Scientific, discusses health equity in pharma, specifically racial biases, and how the industry can address inequities in access and care going forward. 

Market Access